CLINICAL_TRIALS
trial_result
· 2010-11-25
Clinical Trial Update: Study Evaluating Temsirolimus (CCI-779) In Breast Neoplasms [Phase 2]
Summary
A Phase 2 study of temsirolimus (CCI-779) in breast cancer has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Breast Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2010-11-25